Basel Medical Group (NASDAQ:BMGL) Shares Down 5.1% – Time to Sell?

Basel Medical Group Ltd (NASDAQ:BMGL)’s share price dropped 5.1% on Tuesday . The company traded as low as $0.57 and last traded at $0.57. Approximately 11,629 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 35,644 shares. The stock had previously closed at $0.6007.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Basel Medical Group in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Basel Medical Group Price Performance

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.23 and a quick ratio of 1.19. The firm’s 50-day simple moving average is $0.67 and its 200-day simple moving average is $1.21.

Basel Medical Group (NASDAQ:BMGL) last posted its quarterly earnings results on Monday, November 17th. The company reported ($0.25) earnings per share for the quarter. The firm had revenue of $2.60 million for the quarter.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in BMGL. Marex Group plc bought a new position in shares of Basel Medical Group during the second quarter valued at approximately $25,000. Vanguard Personalized Indexing Management LLC bought a new position in Basel Medical Group in the third quarter worth approximately $40,000. Virtu Financial LLC lifted its holdings in Basel Medical Group by 108.8% during the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after buying an additional 17,608 shares during the period. Finally, Citadel Advisors LLC purchased a new stake in Basel Medical Group during the third quarter worth $169,000.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.